000 01637 a2200481 4500
005 20250518010503.0
264 0 _c20190305
008 201903s 0 0 eng d
022 _a1873-2496
024 7 _a10.1016/j.urolonc.2018.10.017
_2doi
040 _aNLM
_beng
_cNLM
100 1 _ada Costa, Walter Henriques
245 0 0 _aLoss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma.
_h[electronic resource]
260 _bUrologic oncology
_c01 2019
300 _a78-85 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aCarcinoma, Renal Cell
_xgenetics
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aKidney Neoplasms
_xgenetics
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aPrognosis
650 0 4 _aProgression-Free Survival
650 0 4 _aRisk Factors
650 0 4 _aTumor Suppressor Proteins
_xbiosynthesis
650 0 4 _aUbiquitin Thiolesterase
_xbiosynthesis
700 1 _aFares, Aline Fusco
700 1 _aBezerra, Stephania M
700 1 _aMorini, Mariana A
700 1 _ade Toledo Benigno, Ligia Alencar
700 1 _aClavijo, Diego Abreu
700 1 _aFornazieri, Lucas
700 1 _aRocha, MaurĂ­cio Murce
700 1 _ada Cunha, Isabela Werneck
700 1 _ade Cassio Zequi, Stenio
773 0 _tUrologic oncology
_gvol. 37
_gno. 1
_gp. 78-85
856 4 0 _uhttps://doi.org/10.1016/j.urolonc.2018.10.017
_zAvailable from publisher's website
999 _c29061649
_d29061649